244 related articles for article (PubMed ID: 239718)
1. Parkinson's disease and its chemotherapy.
Hornykiewicz O
Biochem Pharmacol; 1975 May; 24(10):1061-5. PubMed ID: 239718
[No Abstract] [Full Text] [Related]
2. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
Orzi F; Fornai F; Blandini F
Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
[No Abstract] [Full Text] [Related]
3. Basal ganglia, Parkinson's disease and levodopa therapy. Proceedings of a meeting. St Thomas, Virgin Islands, January 2000.
Trends Neurosci; 2000 Oct; 23(10 Suppl):S1-126. PubMed ID: 11221749
[No Abstract] [Full Text] [Related]
4. [Dopamine agonists in the therapy of parkinson syndrome].
Kapfhammer HP; Rüther E
Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
[No Abstract] [Full Text] [Related]
5. Parkinsonism: candidate disorder for implanted pumps?
Nutt JG
Ann N Y Acad Sci; 1988; 531():194-9. PubMed ID: 2898229
[No Abstract] [Full Text] [Related]
6. [Receptor-mediated Parkinson drugs].
Böckler F
Pharm Unserer Zeit; 2006; 35(3):204-16. PubMed ID: 16724524
[No Abstract] [Full Text] [Related]
7. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.
Kickler N; Krack P; Fraix V; Lebas JF; Lamalle L; Durif F; Krainik A; Rémy C; Segebarth C; Pollak P
NMR Biomed; 2007 Dec; 20(8):757-62. PubMed ID: 17334978
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of the development of akinesia in Parkinson's disease --with reference to L-threo-DOPS therapy].
Narabayashi H
No To Shinkei; 1983 Nov; 35(11):1057-63. PubMed ID: 6362685
[No Abstract] [Full Text] [Related]
9. Potential nondopaminergic drugs for Parkinson's disease.
Silverdale MA; Fox SH; Crossman AR; Brotchie JM
Adv Neurol; 2003; 91():273-91. PubMed ID: 12442686
[No Abstract] [Full Text] [Related]
10. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.
Calabresi P; Mercuri NB; Di Filippo M
Brain; 2009 Feb; 132(Pt 2):285-7. PubMed ID: 19168452
[No Abstract] [Full Text] [Related]
11. Basal ganglia and Parkinson's disease: neurobiological and pharmacological aspects in animals and man.
Cools AR
Clin Neurol Neurosurg; 1984; 86(3):178-95. PubMed ID: 6091966
[TBL] [Abstract][Full Text] [Related]
12. [Parkinson's disease: neuro-anatomical, biochemical and pharmicotherapeutic aspects].
Korf J; van Praagen HM; Lakke JP
Ned Tijdschr Geneeskd; 1975 Sep; 119(36):1373-8. PubMed ID: 241026
[No Abstract] [Full Text] [Related]
13. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
Klivényi P; Vécsei L
Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
[TBL] [Abstract][Full Text] [Related]
14. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
Rajput A; Kishore A; Snow B; Bolton CF; Rajput AH
Mov Disord; 1997 May; 12(3):453-6. PubMed ID: 9159748
[No Abstract] [Full Text] [Related]
15. Current views on Parkinson's disease.
Calne DB
Can J Neurol Sci; 1983 Feb; 10(1):11-5. PubMed ID: 6132677
[TBL] [Abstract][Full Text] [Related]
16. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
17. Levodopa and the progression of Parkinson's disease.
Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K;
N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952
[TBL] [Abstract][Full Text] [Related]
18. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease.
Yokochi M
Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038
[TBL] [Abstract][Full Text] [Related]
19. Pallidotomy in Parkinson's disease.
Temlett JA
S Afr Med J; 1996 Oct; 86(10):1248-9. PubMed ID: 8955725
[No Abstract] [Full Text] [Related]
20. Insidious dopamine: provocateur or protective agent in Parkinson's disease?
Kostrzewa RM; Brus R; Kostrzewa JP
Pol J Pharmacol; 2001; 53(2):165-6. PubMed ID: 11787956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
